Research group for psychosocial and pharmacological interventions in child and adolescent psychiatry

We study effects and mechanisms of interventions across a range of mental disorders, ages, interventions, and approaches. In eating disorders, we study family based therapy (VIBUS cohort study). We study suicide and self-harm prevention with Dialectical Behavior Therapy based interventions and psychoeducational interventions, both face-to-face and online, and in both hospital and school settings (TEENS RCT, YAM-study, iCARE RCT), and investigate characteristics and risk factors (SPACE). In autisms we investigate parent-mediated interventions (DAN-PACT RCT) and in psychosis we study the effects and costs of specialized early intervention (OPUS YOUNG RCT). We are engaged in the Gender Dysphoria Study on psychosocial and somatic factors, and clinical care. We study effects and side effects of antipsychotics (TEA RCT, PROSA cohort, Polypharmacy Study, and collaboration with QUE-MEL RCT from adult psychiatry) and somatic disease associated with antipsychotic treatment (ASEP Register study). We study the effects of family-based CBT for OCD (TECTO RCT), and include substudies of underlying mechanism (neuroimaging, neuropsychology, emotion regulation, neuroendocrine factors), side effects and therapy processes and AI-enhancement). In collaboration with Technical University of Denmark, we investigate the use of wearable biosensors for OCD (Wrist Angel) and other disorders, as well as use of AI and new technologies for assessments and treatment (FAST). We participate in neurobiological studies in affective disorders lead by adult psychiatry (BIO-YOUNG and MIPAD)